Biocon Biopharmaceuticals Limited, a amalgamated public limited company, was established on 17 June 2002 in Bangalore, Karnataka, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24231KA2002PLC030643. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹44.00 Cr and a paid-up capital of ₹17.60 Cr.
Its leadership includes Kiran Mazumdar Shaw (Managing Director), John Mccallum Marshall Shaw (Director), Chinappa Muckatira Bhemaiah (Alternate Director). Past directors included Ernesto Chico Veliz, Kiran Mazumdar Shaw, Patricia De La Asuncion Sierra Blazquez. Its latest AGM occurred on 25 July 2013, with the balance sheet filed on 31 March 2013. It is based at 20Th Km Hosur Road,Electronic City P O Bangalore, Bangalore, Karnataka, 560100.
U24231KA2002PLC030643
030643
17 June 2002
₹44.00 Cr
₹17.60 Cr
Roc Bangalore
Unlisted
Amalgamated
Explore comprehensive insights into Biocon Biopharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Mazumdar Shaw | Managing Director | 17 Jun 2002 | Current |
| John Mccallum Marshall Shaw | Director | 17 Jun 2002 | Current |
| Chinappa Muckatira Bhemaiah | Alternate Director | 22 Mar 2007 | Current |
| Arun Suresh Chandavarkar | Nominee Director | 22 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 28 Apr 2010 | Past |
| Pramod Abcsdd | Director | 22 Mar 2007 | Past |
| Pramod Abcsdd | Nominee Director | 28 Apr 2010 | Past |
| Pramod Abcsdd | Nominee Director | 28 Apr 2010 | Past |
| Pramod Abcsdd | Alternate Director | 28 Apr 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Biocon Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Biocon Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biocon Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biocon Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Biocon Biopharmaceuticals Limited last Annual general meeting of members was held on 25 Jul 2013 as per latest MCA records. was completed.
Biocon Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Bangalore. was recorded as a recent event.
Progress on Chinappa Muckatira Bhemaiah was appointed as a Alternate Director was appointed as a Alternate Director on 22 Mar 2007 & has been associated with this company since 18 years 8 months . was documented.
Progress on Arun Suresh Chandavarkar was appointed as a Nominee Director was appointed as a Nominee Director on 22 Mar 2007 & has been associated with this company since 18 years 8 months . was documented.
The activity Sridevi Bhamidipati was appointed as a Company Secretary was appointed as a Company Secretary on 01 Jul 2005 & has been associated with this company since 20 years 4 months . was completed.
Kiran Mazumdar Shaw was appointed as a Managing Director was appointed as a Managing Director on 17 Jun 2002 & has been associated with this company since 23 years 5 months . was recorded as a recent event.
Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
Sen was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down. He has over 20 years of experience in financial planning, treasury, taxation and financial reporting..
The CIN of Biocon Biopharmaceuticals Limited is U24231KA2002PLC030643.
Biocon Biopharmaceuticals Limited is headquartered at 20Th Km Hosur Road,Electronic City P O Bangalore, Bangalore, Karnataka, 560100.
Biocon Biopharmaceuticals Limited was incorporated on 17 June 2002.
The current directors of Biocon Biopharmaceuticals Limited are
The primary industry of Biocon Biopharmaceuticals Limited is Life Sciences.
Biocon Biopharmaceuticals Limited is unlisted.
The authorized capital of Biocon Biopharmaceuticals Limited is ₹44.00 Cr, and the paid-up capital is ₹17.60 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX